BSE filing, NSE: MARKSANS. Summary written from the filing by ALFA Finder's alert engine.
Marksans Pharma Ltd: key numbers
- Share price
- ₹306.20
- Market cap
- ₹13,876 Cr
- Revenue (annual)
- ₹2,951 Cr
- Net profit (annual)
- ₹417.9 Cr
- P/E (TTM)
- 26.9×Sector 45.9×
- Promoter holding
- 43.87%+0.00% QoQ
- FII holding
- 19.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marksans Pharma Ltd
All →Marksans Pharma Board Meeting Date
Marksans Pharma scheduled its Board meeting for November 4, 2026, to approve Q1/H1 unaudited results. No material decision has been taken yet.
Marksans Pharma Other Announcement
Periodic quarterly shareholding pattern filing for Marksans Pharma Ltd. This document provides the latest breakdown of shareholder categories as mandated by SEBI.
Marksans Pharma Promoter Selling (Off-Market)
Director Sandra Saldanha gifted 2,28,273 shares of Marksans Pharma Ltd to her daughters in an off-market transaction. This internal transfer reallocates promoter-group equity holdings.
Marksans Pharma Other Announcement
Marksans Pharma intimated shareholders about SEBI's extended special window (Feb 2026–Feb 2027) for re-lodgement of pre-April-2019 physical share transfer deeds. No new business, capital, or operational event is disclosed.
Marksans Pharma Annual General Meeting
Marksans Pharma Limited conducted its 34th Annual General Meeting on August 27, 2026. Shareholders considered the adoption of FY2025-26 financial statements and a dividend of Rs. 0.90 per share.
Marksans Pharma Other Announcement
Marksans Pharma Ltd. has received an ESG score of 56 from Crisil ESG Ratings & Analytics Ltd for Fiscal 2026.
Other merger & restructuring announcements
All →KS Smart Technologies Merger & Restructuring Worth ₹0.01 Cr
KS Smart Technologies reported completion of a foreign subsidiary's incorporation, KS Smart Global Inc. in USA, on 22 October 2026. Transaction amount is ₹0.01 Crore.
- Value
- ₹0.01 Cr
KS Smart Technologies Merger & Restructuring
KS Smart Technologies reported that its step-down subsidiary KS Smart Global Inc. was incorporated in Delaware, USA, on October 22, 2026. The initial share subscription is stated as up to USD 510, held 51% by KSSPL.
AXISCADES Technologies Merger & Restructuring
AXISCADES Technologies disclosed that its step-down subsidiary Ulosia Holding AG incorporated AKKODIS AXISCADES AEROSPACE CANADA INC. in Canada. No cash was invested by the listed entity, and no value is stated.
Sapphire Foods India Merger & Restructuring
Sapphire Foods received CCI approval under Section 31(1) for its proposed merger into Devyani International under a Scheme of Arrangement. The detailed CCI order is still awaited.
Aditya Ispat Merger & Restructuring
Aditya Ispat's steel slump sale to related party Jai Bapji Ispat now completes by 31 December 2026. Delay stems from pre-closing actions under the business transfer agreement.
Vahh Chemicals Merger & Restructuring Worth ₹0.1 Cr
VAHH Chemicals will incorporate Vedant Nutrition Limited as a wholly owned nutraceutical subsidiary with Rs 0.10 Crore cash. Incorporation is tentatively dated November 5, 2026.
- Value
- ₹0.10 Cr